MiniMed™ 780G insulin pump system
Experience the #1 pump in preventing highs and lows based on user satisfaction.1-3 Now even easier to use when paired with the new Instinct sensor, made by Abbott.
Goodbye rollercoaster, hello stability
People who used the MiniMed™ 780G system benefited from automatic insulin adjustments and corrections every 5 minutes,† providing more consistency and fewer surprises.
Get more out of your diabetes management
The system adjusts insulin while you sleep, meaning fewer beeps and alarms.
The system requires as few as 6 device insertions a month with the 15-day Instinct sensor and 7-day Extended™ infusion set.§◊
The system works with multiple sensors, including the new Instinct sensor, made by Abbott, and the Simplera Sync™ sensor. See options
Frequently asked questions
Medtronic insulin pumps are covered by most insurance plans. Your out-of-pocket cost varies depending on your insurance. We also offer financial assistance and monthly payment programs. If you would like to receive an insurance coverage check, call us at 1-888-350-5440 (M-F 9:00 a.m. – 6:00 p.m. CT).
For customers currently on a Medtronic insulin pump, sign in to Diabetes.shop to see your options.
The Simplera Sync sensor has coverage for Medicare, Medicare Advantage, and commercial insurance under your medical benefit. If your health plan requires you to use your pharmacy benefit, we will verify if the Simplera Sync sensor is covered by your plan.
The Instinct sensor has coverage for commercial insurance under your medical benefit. If your health plan requires you to use your pharmacy benefit, we will verify if the Instinct sensor is covered by your plan. If you have Medicare or Medicare Advantage, please note that we are currently waiting for billing code approval, which is expected in January 2026. In the meantime, you may place an order for the Instinct sensor and we'll process and ship your order at that time.
In a case of non-coverage, Medtronic offers programs to assist with access.
No. The only sensor made by Abbott that works with the MiniMed 780G system is the Instinct sensor.
If you currently use an in-warranty insulin pump from another company, you may be eligible for our Switch2System program when you trade in your current device.
Simply trade in your existing pump and pay an upgrade fee of just $499 to switch to the MiniMed™ 780G system. If it doesn’t work out, no problem! Just return it within 90 days. Learn more about our Switch2System program.
© Medtronic. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image © Abbott. ™*Third–party brands are trademarks of their respective owners.
Footnotes
† Refers to auto correct, which provides bolus assistance. Can deliver all correction doses automatically without user interaction, feature can be turned on and off.
‡ Due to inherent real-world study limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences. Overnight period: 3:00 AM- 6:00 AM. Number of users with ≥10 days of sensor glucose data; Optimal settings are glucose target at 100 mg/dL (5.5 mmol/L) and Active Insulin Time (AIT) at 2 hours and used >95% of the time.
§ Based on usage of 2 Instinct sensors for 15 days each and 4 Extended Infusion Sets for 7 days each in a one-month period. More insertions may be required if Instinct sensor or Extended infusion set requires replacement before specified wear time.
◊ Fingersticks required in manual mode & to enter SmartGuard™. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard™.
1. Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed.
2. Individual results may vary.
3. dQ&A US Patient Voice Q2 2025.p. 77. N=215.
5. McVean, et al. 972-P: Hyperglycemia from Real-World Dawn Phenomenon Is Nearly Eliminated with the MiniMed 780G System (MM780G). Diabetes 14 June 2024; 73 (Supplement_1): 972–P. 972-P: Hyperglycemia from Real-World Dawn Phenomenon Is Nearly Eliminated with the MiniMed 780G System (MM780G)
Important Safety Information: MiniMed™ 780G system with SmartGuard™ technology with Instinct sensor, Simplera Sync™ sensor, and Guardian™ 4 sensor
The MiniMed™ 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older using the Instinct, Simplera Sync™ or Guardian™ 4 sensor, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin using the Simplera Sync™ or Guardian™ 4 sensor.
The MiniMed™ 780G System includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera Sync™ and Guardian™ 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.
WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.
WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes using the Instinct sensor, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including accessories and additional important safety information concerning indications, contraindications, warnings and precautions associated with the system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information and the appropriate user guide at https://www.medtronicdiabetes.com/download-library.